DSpace@İnönü

Yazar "Hacioglu, S" için listeleme

Yazar "Hacioglu, S" için listeleme

Sırala: Sıra: Sonuçlar:

  • MANAGEMENT OF MANTLE CELL LYMPHOMA IN THE ELDERLY: A RETROSPECTIVE 
    Keklik, M; Dogu, M; Nizam, I; Terzi, H; Hacioglu, S; Erkurt, M; Keskin, A; Eser, B; Cetin, M; Unal, A; Ilhan, O (2014)
  • HAIRY CELL LEUKEMIA: MULTICENTER RETROSPECTIVE ANALYSIS IN TURKEY 
    Hacioglu, S; Bilen, Y; Eser, A; Sivgin, S; Gurkan, E; Yildirim, R; Aydogdu, I; Dogu, MH; Yilmaz, M; Kayikci, O; Tombak, A; Kuku, I; Celebi, H; Akay, MO; Esen, R; Korkmaz, S; Keskin, A (2014)
  • Clinical characteristics and therapeutic outcomes of elderly patients 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, S; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2015)
    AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase ...
  • Multicenter retrospective analysis regarding the clinical manifestations 
    Hacioglu, S; Bilen, Y; Eser, A; Sivgin, S; Gurkan, E; Yildirim, R; Aydogdu, I; Dogu, MH; Yilmaz, M; Kayikci, O; Tombak, A; Kuku, I; Celebi, H; Akay, MO; Esen, R; Korkmaz, S; Keskin, A (2015)
    In this multicenter retrospective analysis, we aimed to present clinical, laboratory and treatment results of 94 patients with Hairy cell leukemia diagnosed in 13 centers between 1990 and 2014. Sixty-six of the patients ...
  • Clinical characteristics and therapeutic outcomes of elderly patients 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, S; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2015)
    AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase ...
  • Multicenter retrospective analysis regarding the clinical manifestations 
    Hacioglu, S; Bilen, Y; Eser, A; Sivgin, S; Gurkan, E; Yildirim, R; Aydogdu, I; Dogu, MH; Yilmaz, M; Kayikci, O; Tombak, A; Kuku, I; Celebi, H; Akay, MO; Esen, R; Korkmaz, S; Keskin, A (2015)
    In this multicenter retrospective analysis, we aimed to present clinical, laboratory and treatment results of 94 patients with Hairy cell leukemia diagnosed in 13 centers between 1990 and 2014. Sixty-six of the patients ...
  • Clinical characteristics and therapeutic outcomes of elderly patients 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, S; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2015)
    AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase ...
  • Multicenter retrospective analysis regarding the clinical manifestations 
    Hacioglu, S; Bilen, Y; Eser, A; Sivgin, S; Gurkan, E; Yildirim, R; Aydogdu, I; Dogu, MH; Yilmaz, M; Kayikci, O; Tombak, A; Kuku, I; Celebi, H; Akay, MO; Esen, R; Korkmaz, S; Keskin, A (2015)
    In this multicenter retrospective analysis, we aimed to present clinical, laboratory and treatment results of 94 patients with Hairy cell leukemia diagnosed in 13 centers between 1990 and 2014. Sixty-six of the patients ...
  • CLINICAL CHARACTERISTICS, POST-TREATMENT ASSESSMENT AND PROGNOSTIC 
    Berber, I; Erkurt, MA; Keklik, M; Dogu, MH; Terzi, H; Pala, C; Sari, HI; Sencan, M; Sivgin, S; Hacioglu, S; Altuntas, F; Aydogdu, I; Ilhan, O (2015)
    Introduction: During the last three decades, major advances have been made in the therapy of Hodgkin's lymphoma. However, despite these advances, Hodgkin's lymphoma has a poor prognosis in the elderly. The proportion of ...
  • Clinical characteristics and therapeutic outcomes of elderly patients 
    Korkmaz, S; Dal, MS; Berber, I; Sahin, DG; Dogu, MH; Ayyildiz, O; Nizam, I; Albayrak, M; Esen, R; Namdaroglu, S; Sencan, M; Akay, OM; Hacioglu, S; Yildirim, R; Eser, A; Tombak, A; Pala, C; Ilhan, O (2015)
    AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase ...
  • Autologous stem cell transplantation and stem cell mobilization kinetics 
    Dogu, MH; Cagirgan, S; Ocakci, S; Kaya, AH; Ilkkilic, K; Sanli, NM; Kahraman, S; Eren, R; Tekgunduz, E; Hacioglu, S; Kaynar, L; Erkurt, MA; Altuntas, F (2017)
    As known, the world population is aging and as the life span increases the number of advanced-age lymphomas also shows an upward trend. Autologous hematopoietic stem cell transplantation (HSCT) is the standard treatment ...
  • Autologous stem cell transplantation and stem cell mobilization kinetics 
    Dogu, MH; Cagirgan, S; Ocakci, S; Kaya, AH; Ilkkilic, K; Sanli, NM; Kahraman, S; Eren, R; Tekgunduz, E; Hacioglu, S; Kaynar, L; Erkurt, MA; Altuntas, F (2017)
    As known, the world population is aging and as the life span increases the number of advanced-age lymphomas also shows an upward trend. Autologous hematopoietic stem cell transplantation (HSCT) is the standard treatment ...
  • Stem cell mobilization kinetics in elderly patients with multiple 
    Dogu, MH; Batgi, H; Erkurt, MA; Hacioglu, S; Tekgunduz, E; Kaya, E; Iskender, D; Eren, R; Kuku, I; Altuntas, F (2018)
    In this study, we aimed to investigate whether the procedure and product kinetics differ according to age groups in advanced-age MM patients who underwent autologous HSCT. 59 patients who underwent autologous HSCT were ...
  • Stem cell mobilization kinetics in elderly patients with multiple 
    Dogu, MH; Batgi, H; Erkurt, MA; Hacioglu, S; Tekgunduz, E; Kaya, E; Iskender, D; Eren, R; Kuku, I; Altuntas, F (2018)
    In this study, we aimed to investigate whether the procedure and product kinetics differ according to age groups in advanced-age MM patients who underwent autologous HSCT. 59 patients who underwent autologous HSCT were ...
  • Stem cell mobilization kinetics in elderly patients with multiple 
    Dogu, MH; Batgi, H; Erkurt, MA; Hacioglu, S; Tekgunduz, E; Kaya, E; Iskender, D; Eren, R; Kuku, I; Altuntas, F (2018)
    In this study, we aimed to investigate whether the procedure and product kinetics differ according to age groups in advanced-age MM patients who underwent autologous HSCT. 59 patients who underwent autologous HSCT were ...
  • Evolution of clinical characteristics of patients with paroxysmal 
    Karadag, FK; Yenerel, MN; Yilmaz, M; Uskudar, H; Ozkocaman, V; Tuglular, TF; Erdem, F; Unal, A; Ayyildiz, O; Ozet, G; Comert, M; Kaya, E; Ayer, M; Salim, O; Guvenc, B; Ozdogu, H; Mehtap, O; Sonmez, M; Guler, N; Hacioglu, S; Aydogdu, I; Bektas, O; Toprak, SK; Kaynar, L; Yagci, M; Aksu, S; Tombak, A; Karakus, V; Yavasoglu, I; Onec, B; Ozcan, MA; Undar, L; Ali, R; Ilhan, O; Saydam, G; Sahin, F (2021)
    Paroxysmal nocturnal hemoglobinuria (PNH) is a rare X-linked genetic disorder. On the contrary to its name, it is a multisystemic disease and various symptoms other than hemoglobinuria could be occurred. It could be life ...